NTLA Free Cash Flow Growth
Intellia Therapeutics Inc · Free Cash Flow Growth
NTLA Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported17.34%period ending
NTLA TTM Free Cash Flow YoY % (1569.34% → 17.34%)
Year-over-year change
High-resolution chart · PNG
NTLA free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 17.3373% | |
| 4.5992% | |
| -11.6188% | |
| -13.6546% | |
| -10.2351% | |
| 8.8318% | |
| 13.0891% | |
| 10.8579% | |
| 0.4358% | |
| -10.3766% | |
| -4.1856% | |
| -14.5922% | |
| -12.307% | |
| -22.5571% | |
| -64.7183% | |
| -60.459% | |
| -88.8639% | |
| -348.5957% | |
| -344.4847% | |
| -409.2048% | |
| -337.2572% | |
| 45.5108% | |
| 51.3814% | |
| 51.0862% | |
| 45.621% | |
| -78.1294% | |
| -62.7361% | |
| -9.5359% | |
| 11.2586% | |
| 10.6337% | |
| 10.2857% | |
| -16.8526% | |
| -46.6894% | |
| -420.1024% | |
| -351.6932% | |
| -267.7467% | |
| -227.9143% | |
| 230.2383% | |
| 793.6298% | |
| 3,786.6044% | |
| 1,569.3416% |